Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ICC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07432568
What this trial is testing

Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)WithdrawnNCT04682249
What this trial is testing

Systemic Chemotherapy, Apatinib Plus Sintilimab for Metastasis ICC

Who this might be right for
ICC
Sun Yat-sen University
Testing effectiveness (Phase 2)UnknownNCT06033118
What this trial is testing

Gemox Combined With Anlotinib and Sintilimab in Advanced cHCC-ICC

Who this might be right for
Combined Hepatocellular Cholangiocarcinoma
Sichuan University 25
Not applicableStudy completedNCT03893851
What this trial is testing

Preventing Violence by Teachers

Who this might be right for
Violence by Teachers
Bielefeld University 914
Testing effectiveness (Phase 2)Looking for participantsNCT06852287
What this trial is testing

Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Gall Bladder Cancer
Tianjin Medical University Cancer Institute and Hospital 33
Not applicableLooking for participantsNCT07476651
What this trial is testing

Scout Dose of Resin Microspheres

Who this might be right for
RadioembolizationHepatocellular Carcinoma (HCC)Intrahepatic Cholangiocarcinoma (ICC)+1 more
Seoul National University Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT04989218
What this trial is testing

Durvalumab and Tremelimumab With Platinum-based Chemotherapy in Intrahepatic Cholangiocarcinoma (ICC)

Who this might be right for
Cholangiocarcinoma
University of Alabama at Birmingham 1
Not applicableUnknownNCT02983539
What this trial is testing

Detection of Circulating Tumor Cells in Patients With Sarcomas

Who this might be right for
LeiomyosarcomaPleomorphic LiposarcomaSynovial Sarcoma+1 more
AC Camargo Cancer Center 20
Large-scale testing (Phase 3)UnknownNCT04961970
What this trial is testing

HAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shi Ming 188
Not applicableStudy completedNCT05081622
What this trial is testing

Preventing Violence by Teachers in Primary Schools in Haiti

Who this might be right for
Violence by Teachers
Bielefeld University 1,064
Not applicableStudy completedNCT07153783
What this trial is testing

Interventional AI-Human Collaboration for Liver Tumor Diagnosis

Who this might be right for
Hepatocellular Carcinoma (HCC)Intrahepatic Cholangiocarcinoma (Icc)Hepatic Metastasis+3 more
Shengjing Hospital 10,333
Not applicableNot Yet RecruitingNCT07768085
What this trial is testing

Pragmatic RCT of AI-Assisted Reading for Malignant Hepatic Lesions on CE-CT

Who this might be right for
Hepatocellular Carcinoma (HCC)Intrahepatic Cholangiocarcinoma (Icc)Hepatic Metastasis+3 more
Shengjing Hospital 40,000
Not applicableLooking for participantsNCT07101237
What this trial is testing

An Exploratory Study on Developing an Integrated Approach Combining Multimodal Imaging and Multi-omics Characterization of Tumor Heterogeneity for Precision Diagnosis and Treatment Optimization in Liver Cancer.

Who this might be right for
Hepatocellular Carcinoma (HCC)Intrahepatic Cholangiocarcinoma (ICC)Primary Liver Cancer
Peking Union Medical College Hospital 308
Testing effectiveness (Phase 2)UnknownNCT04782804
What this trial is testing

Adjuvant PD-1 Antibody in Combination With Capecitabine for Patients With ICC at High-Risk of Postoperative Recurrence

Who this might be right for
Cholangiocarcinoma, Intrahepatic
Fudan University 30
Not applicableStudy completedNCT01221987
What this trial is testing

Cross-sectional Study on Human Papillomavirus Type Distribution in Adult Women Diagnosed With Cervical Cancer

Who this might be right for
Neoplasms, Uterine CervixCervical Cancer
GlaxoSmithKline 40
Testing effectiveness (Phase 2)UnknownNCT05781958
What this trial is testing

Cadonilimab Combined With Gem/Cis as First Line Therapy in Patients With Advanced ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shen Feng 64
Testing effectiveness (Phase 2)Looking for participantsNCT05678270
What this trial is testing

ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (ICC)
Beijing InnoCare Pharma Tech Co., Ltd. 70
Not applicableUnknownNCT05200234
What this trial is testing

Improving Cerebral Blood Flow and Cognitive Function in Patients With Asymptomatic Intracranial / Carotid Stenosis With Nattokinase (ICC-PACS)

Who this might be right for
Cerebral Blood FlowCognitive Function
Second Affiliated Hospital, Zhejiang University, School of Medicine 100
Not applicableLooking for participantsNCT07640048
What this trial is testing

Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Peking Union Medical College Hospital 90
Large-scale testing (Phase 3)Looking for participantsNCT05342194
What this trial is testing

Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Junshi Bioscience Co., Ltd. 480
Next Page